Terraflos key facts
as of Oct 2026- Developer of a consumer science platform that integrates biotechnology, AI, and branded products designed to create bioactives that support health, wellness, and longevity.
- Terraflos is valued at approximately $62.0M as of Oct 2026 (last reported valuation).
- It has raised $14.0M; the latest was Early Stage VC in Dec 2026.
- Notable investors include Acelerar España, Alejandro Dillon, Camilo Villalba, FL Ventures, Facundo Belocopitt — 22 tracked in total.
- Status: Privately Held (backing).
Terraflos's last reported valuation, Aug 2021. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch Terraflos: the Monday email on marks, rounds and moves
Terraflos funding rounds
No funding rounds for Terraflos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Terraflos
22+Terraflos valuation
Terraflos's last reported valuation was $62 million in Aug 2021. No priced round, secondary trade or fund mark has surfaced since.
Terraflos investors
22 investors are on record for Terraflos, including Acelerar España, Alejandro Dillon, Camilo Villalba and FL Ventures.
About Terraflos
Developer of a consumer science platform that integrates biotechnology, AI, and branded products designed to create bioactives that support health, wellness, and longevity. The company offers vertically integrated R&D, manufacturing, and commercialization capabilities across supplements, functional foods, and skincare, enabling health-conscious consumers to access sustainable, high-quality, science-backed products.
- Sector
- Healthcare
- HQ
- Road Town, British Virgin Islands
- Founded
- 2021
- Employees
- 90
- Website
- terraflos.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.